Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anecortave Acetate for Idiopathic Perifoveal Telangiectasia
NCT00211328Phase 2Completed
- Sponsor
- Manhattan Eye, Ear and Throat Hospital
- Start
- Mar 2002
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of anecortave in idiopathic juxtafoveal telangiectasia (IJT), sponsored by Manhattan Eye, Ear and Throat Hospital. Started Mar 2002; status: completed.
02
Drugs
anecortave
03
Conditions
idiopathic juxtafoveal telangiectasia (IJT)
Beyond the preview
Go deeper on NCT00211328.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00211328.